Literature DB >> 14280441

THE DETERMINATION OF ANTIBODY TO GROUP A STREPTOCOCCAL POLYSACCHARIDE IN HUMAN SERA BY HEMAGGLUTINATION.

W C SCHMIDT, D J MOORE.   

Abstract

A hemagglutination method employing tanned human O erythrocytes sensitized with purified Group A streptococcal polysaccharide has been developed to measure A polysaccharide antibody in antistreptococcal rabbit and human sera. The reaction of sensitized RBC with known Group A streptococcal rabbit antisera, inhibition of hemagglutination with A polysaccharide, and abolition of hemagglutination and hemagglutination-inhibition by exposure of polysaccharide antigen to A enzyme, which destroys the specific immunologic determinant of A carbohydrate, were utilized to demonstrate the specificity of this hemagglutinating system. The results of A polysaccharide antibody determinations on sera from normal persons, patients convalescent from streptococcal infection, and patients with non-suppurative streptococcal sequelae are presented.

Entities:  

Keywords:  ANTIBODIES; CARRIER STATE; CHILD; CHROMATOGRAPHY; EXPERIMENTAL LAB STUDY; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TESTS; NEPHRITIS; POLYSACCHARIDES, BACTERIAL; RABBITS; RHEUMATIC FEVER; SEPTICEMIA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS

Mesh:

Substances:

Year:  1965        PMID: 14280441      PMCID: PMC2138003          DOI: 10.1084/jem.121.5.793

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Antibody titers in acute rheumatic fever.

Authors:  L W WANNAMAKER; E M AYOUB
Journal:  Circulation       Date:  1960-04       Impact factor: 29.690

2.  Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells.

Authors:  A B STAVITSKY
Journal:  J Immunol       Date:  1954-05       Impact factor: 5.422

3.  THE LYSIS OF CELL WALLS OF GROUP A STREPTOCOCCI BY STREPTOMYCES ALBUS ENZYME TREATED WITH DIISOPROPYL FLUOROPHOSPHATE. CHARACTERISTICS OF THE LYTIC REACTION AND THE SOLUBLE CELL WALL FRAGMENTS.

Authors:  W C SCHMIDT
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

4.  Studies on the chemical structure of the streptococcal cell wall. I. The identification of a mucopeptide in the cell walls of groups A and A-variant streptococci.

Authors:  R M KRAUSE; M MCCARTY
Journal:  J Exp Med       Date:  1961-07-01       Impact factor: 14.307

5.  THE CELLULAR ANTIGENS OF GROUP A STREPTOCOCCI; IMMUNOELECTROPHORETIC STUDIES OF THE C, M, T, PGP, E4, F, AND E ANTIGENS OF SEROTYPE 17 STREPTOCOCCI.

Authors:  A T WILSON; G G WILEY
Journal:  J Exp Med       Date:  1963-10-01       Impact factor: 14.307

6.  Studies on L forms and protoplasts of group A streptococci. II. Chemical and immunological properties of the cell membrane.

Authors:  E H FREIMER
Journal:  J Exp Med       Date:  1963-03-01       Impact factor: 14.307

7.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : III. CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF THE SPECIES-SPECIFIC SUBSTANCE.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-02-29       Impact factor: 14.307

8.  Variation in the group-specific carbohydrate of group A streptococci. II. Studies on the chemical basis for serological specificity of the carbohydrates.

Authors:  M MCCARTY
Journal:  J Exp Med       Date:  1956-11-01       Impact factor: 14.307

9.  Further studies on the chemical basis for serological specificity of Group A streptococcal carbohydrate.

Authors:  M McCARTY
Journal:  J Exp Med       Date:  1958-09-01       Impact factor: 14.307

10.  Group A polysaccharide precipitin reactions in acute streptococcosis and rheumatic fever.

Authors:  L WEINSTEIN
Journal:  Yale J Biol Med       Date:  1953-04
View more
  13 in total

1.  A latex agglutination test for the measurement of antibodies to group-specific streptococcal polysaccharides.

Authors:  H H Erwa; W R Maxted; W D Brighton
Journal:  Clin Exp Immunol       Date:  1969-03       Impact factor: 4.330

2.  "Immune complexes" in every cutaneous vasculitis with "immune deposits"?

Authors:  F Weidner
Journal:  Arch Dermatol Res       Date:  1979-02-23       Impact factor: 3.017

Review 3.  Streptococcal rheumatic carditis.

Authors:  S K Unny; B L Middlebrooks
Journal:  Microbiol Rev       Date:  1983-03

Review 4.  Detection of immune complexes in acute rheumatic fever and their relationship to HLA-B5.

Authors:  S Yoshinoya; R M Pope
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

5.  [Detection by hemagglutination of antibodies to group A and group E streptococci by the use of O-stearoyl derivatives of their cell wall carbohydrate-grouping antigens].

Authors:  H D Slade; U Hammerling
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

6.  Immune response to extracellular and somatic antigens in streptococcal infection and sequelae.

Authors:  S Bergner-Rabinowitz; M Ferne; H Karshai
Journal:  Inflammation       Date:  1979-09       Impact factor: 4.092

7.  THE LYSIS OF CELL WALLS OF GROUP A STREPTOCOCCI BY STREPTOMYCES ALBUS ENZYME TREATED WITH DIISOPROPYL FLUOROPHOSPHATE. CHARACTERISTICS OF THE LYTIC REACTION AND THE SOLUBLE CELL WALL FRAGMENTS.

Authors:  W C SCHMIDT
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

8.  Qualitative and quantitative aspects of the human antibody response to streptococcal group A carbohydrate.

Authors:  S T Shulman; E M Ayoub
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

9.  Comparison of the titres of ASO, anti-DNase B, and antibodies against the group polysaccharide of group A streptococci in children with streptococcal infections.

Authors:  L E Goedvok-de Groot; N Michel-Bensink; M M van Es-Boon; A H van Vonno; M F Michel
Journal:  J Clin Pathol       Date:  1974-11       Impact factor: 3.411

10.  Enzyme-linked immunosorbent assay for anti-streptococcal protoplast membrane antibodies.

Authors:  N Banchuin; J Wheeler; M Sussman
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.